title: [Fully length MDR1 cDNA transfer conferring resistance to adriamycine on sensitive cells GLC].
abstract: Human lung cancer leads the mortality of cancers and the chemotherapy is often uneffective because of drug resistance. In order to study the role of mdr-1 gene in resistant lung cancer, the fully length mdr-1 cDNA was transferred into a sensitive lung cancer cell line GLC. The mdr-1 cDNA was constructed in a retroviral vector, pDORneo. The transfection of recombinant plasmid was carried out by lipofectin. Supernatant containing infective viruses derived from a G418 resistant clone of package cell PA317 was used to infect GLC cell which is sensitive to chemotherapeutic agents. After G418 and adriamycine selections, three P-glycoprotein positive clones were isolated and the integration of mdr-1 cDNA was demonstrated by PCR of genomic DNA. The relative resistance of 3 clones to adriamycine as and elevated by 5.4, 6.0 respectively 7.8 times compared with the untransfected cell and the transcription of mdr-1 gene in these transfected cells as obviously enhanced by in situ hybridization. This results suggest that the mdr-1 gene plays a role in increasing drug resistance of human lung cancer.
authors.affiliation: Cancer Institute, CAMS, Beijing.
authors.forename: Z
authors.initials: Z
authors.lastname: Zhou
authors.forename: C
authors.initials: C
authors.lastname: Lin
authors.forename: F
authors.initials: F
authors.lastname: Chen
authors.forename: X
authors.initials: X
authors.lastname: Luo
authors.forename: H
authors.initials: H
authors.lastname: Wei
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D018076:DNA, Complementary / Q000235:genetics; D004317:Doxorubicin / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm; D018014:Gene Transfer Techniques; D019450:Genes, MDR; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D018076:DNA, Complementary; D004317:Doxorubicin